The subunit vaccine H65 + CAF01 increased the BCG- protection against Mycobacterium bovis infection in a mouse model of bovine tuberculosis

H65, a fusion protein of three pairs of ESX-secreted antigens of Mycobacterium tuberculosis and Mycobacterium bovis, formulated with the liposomal adjuvant CAF01 has been shown to confer protection against M. tuberculosis infection in mice. In this study, we evaluated the impact of combining BCG wit...

Full description

Bibliographic Details
Main Authors: Blanco, Federico Carlos, Garcia, Elizabeth Andrea, Aagaard, Claus, Bigi, Fabiana
Format: Artículo
Language:Inglés
Published: Elsevier 2021
Subjects:
Online Access:http://hdl.handle.net/20.500.12123/10917
https://www.sciencedirect.com/science/article/abs/pii/S0034528821001132
https://doi.org/10.1016/j.rvsc.2021.04.014
_version_ 1855484680568045568
author Blanco, Federico Carlos
Garcia, Elizabeth Andrea
Aagaard, Claus
Bigi, Fabiana
author_browse Aagaard, Claus
Bigi, Fabiana
Blanco, Federico Carlos
Garcia, Elizabeth Andrea
author_facet Blanco, Federico Carlos
Garcia, Elizabeth Andrea
Aagaard, Claus
Bigi, Fabiana
author_sort Blanco, Federico Carlos
collection INTA Digital
description H65, a fusion protein of three pairs of ESX-secreted antigens of Mycobacterium tuberculosis and Mycobacterium bovis, formulated with the liposomal adjuvant CAF01 has been shown to confer protection against M. tuberculosis infection in mice. In this study, we evaluated the impact of combining BCG with H65 + CAF01 immunization in a M. bovis mouse model of infection. We found that a BCG-H65 + CAF01/ H65 + CAF01 prime-boost scheme induced higher protection than BCG and H65 + CAF01 alone. Altogether, H65 antigen formulated in liposomal adjuvant improved the BCG-induced immune protection, thus making this vaccine strategy a promising tool to control bovine tuberculosis.
format Artículo
id INTA10917
institution Instituto Nacional de Tecnología Agropecuaria (INTA -Argentina)
language Inglés
publishDate 2021
publishDateRange 2021
publishDateSort 2021
publisher Elsevier
publisherStr Elsevier
record_format dspace
spelling INTA109172021-12-15T16:26:45Z The subunit vaccine H65 + CAF01 increased the BCG- protection against Mycobacterium bovis infection in a mouse model of bovine tuberculosis Blanco, Federico Carlos Garcia, Elizabeth Andrea Aagaard, Claus Bigi, Fabiana Mycobacterium bovis Vacuna Control de Enfermedades Infección por Mycobacterium Bovis Vaccines Disease Control Mycobacterium Bovis Infections Tuberculosis Bovina Bovine Tuberculosis H65, a fusion protein of three pairs of ESX-secreted antigens of Mycobacterium tuberculosis and Mycobacterium bovis, formulated with the liposomal adjuvant CAF01 has been shown to confer protection against M. tuberculosis infection in mice. In this study, we evaluated the impact of combining BCG with H65 + CAF01 immunization in a M. bovis mouse model of infection. We found that a BCG-H65 + CAF01/ H65 + CAF01 prime-boost scheme induced higher protection than BCG and H65 + CAF01 alone. Altogether, H65 antigen formulated in liposomal adjuvant improved the BCG-induced immune protection, thus making this vaccine strategy a promising tool to control bovine tuberculosis. Instituto de Biotecnología Fil: Blanco, Federico Carlos. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Agrobiotecnología y Biología Molecular; Argentina Fil: Blanco, Federico Carlos. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Garcia, Elizabeth Andrea. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Agrobiotecnología y Biología Molecular; Argentina Fil: Garcia, Elizabeth Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Aagaard, Claus. Statens Serum Institut. Department of Infectious Disease Immunology; Dinamarca Fil: Bigi, Fabiana. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Agrobiotecnología y Biología Molecular; Argentina. Fil: Bigi, Fabiana. Consejo Nacional de investigaciones Científicas y Tecnológicas; Argentina 2021-12-15T16:23:28Z 2021-12-15T16:23:28Z 2021-05 info:ar-repo/semantics/artículo info:eu-repo/semantics/article info:eu-repo/semantics/acceptedVersion http://hdl.handle.net/20.500.12123/10917 https://www.sciencedirect.com/science/article/abs/pii/S0034528821001132 0034-5288 https://doi.org/10.1016/j.rvsc.2021.04.014 eng info:eu-repograntAgreement/INTA/2019-PD-E5-I102-001/2019-PD-E5-I102-001/AR./Desarrollo de vacunas y tecnologías para mejorar las estrategias profilácticas y terapéuticas de las enfermedades que afectan la producción animal y la salud pública info:eu-repo/semantics/embargoedAccess application/pdf Elsevier Research in Veterinary Science 136 : 595-597 (May 2021)
spellingShingle Mycobacterium bovis
Vacuna
Control de Enfermedades
Infección por Mycobacterium Bovis
Vaccines
Disease Control
Mycobacterium Bovis Infections
Tuberculosis Bovina
Bovine Tuberculosis
Blanco, Federico Carlos
Garcia, Elizabeth Andrea
Aagaard, Claus
Bigi, Fabiana
The subunit vaccine H65 + CAF01 increased the BCG- protection against Mycobacterium bovis infection in a mouse model of bovine tuberculosis
title The subunit vaccine H65 + CAF01 increased the BCG- protection against Mycobacterium bovis infection in a mouse model of bovine tuberculosis
title_full The subunit vaccine H65 + CAF01 increased the BCG- protection against Mycobacterium bovis infection in a mouse model of bovine tuberculosis
title_fullStr The subunit vaccine H65 + CAF01 increased the BCG- protection against Mycobacterium bovis infection in a mouse model of bovine tuberculosis
title_full_unstemmed The subunit vaccine H65 + CAF01 increased the BCG- protection against Mycobacterium bovis infection in a mouse model of bovine tuberculosis
title_short The subunit vaccine H65 + CAF01 increased the BCG- protection against Mycobacterium bovis infection in a mouse model of bovine tuberculosis
title_sort subunit vaccine h65 caf01 increased the bcg protection against mycobacterium bovis infection in a mouse model of bovine tuberculosis
topic Mycobacterium bovis
Vacuna
Control de Enfermedades
Infección por Mycobacterium Bovis
Vaccines
Disease Control
Mycobacterium Bovis Infections
Tuberculosis Bovina
Bovine Tuberculosis
url http://hdl.handle.net/20.500.12123/10917
https://www.sciencedirect.com/science/article/abs/pii/S0034528821001132
https://doi.org/10.1016/j.rvsc.2021.04.014
work_keys_str_mv AT blancofedericocarlos thesubunitvaccineh65caf01increasedthebcgprotectionagainstmycobacteriumbovisinfectioninamousemodelofbovinetuberculosis
AT garciaelizabethandrea thesubunitvaccineh65caf01increasedthebcgprotectionagainstmycobacteriumbovisinfectioninamousemodelofbovinetuberculosis
AT aagaardclaus thesubunitvaccineh65caf01increasedthebcgprotectionagainstmycobacteriumbovisinfectioninamousemodelofbovinetuberculosis
AT bigifabiana thesubunitvaccineh65caf01increasedthebcgprotectionagainstmycobacteriumbovisinfectioninamousemodelofbovinetuberculosis
AT blancofedericocarlos subunitvaccineh65caf01increasedthebcgprotectionagainstmycobacteriumbovisinfectioninamousemodelofbovinetuberculosis
AT garciaelizabethandrea subunitvaccineh65caf01increasedthebcgprotectionagainstmycobacteriumbovisinfectioninamousemodelofbovinetuberculosis
AT aagaardclaus subunitvaccineh65caf01increasedthebcgprotectionagainstmycobacteriumbovisinfectioninamousemodelofbovinetuberculosis
AT bigifabiana subunitvaccineh65caf01increasedthebcgprotectionagainstmycobacteriumbovisinfectioninamousemodelofbovinetuberculosis